Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause permanent, non-reversible hair loss similar to pattern baldness.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

A man's sudden hair loss and color change to white was diagnosed as alopecia areata and it improved on its own after six months.

Epinephrine does not significantly affect the severity of hair loss after surgery.

The four main causes of hair loss in children are fungal infections, pulling out hair, autoimmune hair loss, and stress-related hair shedding.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Children's hair loss can be caused by many factors, including autoimmune diseases, emotional stress, genetics, and infections, with treatment and prognosis varying.

Stopping the beta-blocker nadolol led to quick hair regrowth and improved scalp condition.

A woman's hair grew back after treatment for a rare hair loss caused by proton therapy.

The document concludes that hair loss in women is complex, often linked to aging, health conditions, and nutritional deficiencies, and emotional impacts should not be underestimated.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Doctors should diagnose hair loss by examining the patient and possibly doing tests, and then treat it based on the type, which may prevent permanent hair loss.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Weight loss can cause temporary hair loss, especially in women and older adults.

The pull test and wash test are cheap, easy methods to diagnose hair loss.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

A man experienced hair loss from radiotherapy, which can be temporary or permanent depending on radiation dose, with potential treatments available.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

A 2-year-old girl had a hair disorder not shared by her identical twin.

Two teenage brothers had a rare, treatment-resistant form of female-pattern hair loss with unusual scalp changes.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Colchicine causes hair loss by damaging hair follicles.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.

Aconiti Ciliare Tuber extract may help hair grow by activating a specific cell signaling pathway.